How the duration period of erythropoietin treatment influences the oxidative status of hemodialysis patients.

Int J Med Sci · 2012 · PMC3491441 · PMID 23136545

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Increased periods of EPO treatment were associated with a stepwise decrease in RCG, but the differences between patient subgroups did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.